Stockreport

BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
PDF NESS ZIONA, Israel, Aug. 14, 2018  /PRNewswire/ --- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), developer of M-001, a clinical phase 3 Universal Influenza Vaccine cand [Read more]